These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6153704)

  • 1. Cerebrospinal fluid lipids in demyelinating disease. I. Sphingolipids.
    Seidel D; Buck R; Heipertz R; Pilz H
    J Neurol; 1980 Jan; 222(3):171-6. PubMed ID: 6153704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid lipids in demyelinating disease. II. Linoleic acid as an index of impaired blood-CSF barrier.
    Seidel D; Heipertz R; Weisner B
    J Neurol; 1980 Jan; 222(3):177-82. PubMed ID: 6153705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain-Barré syndrome.
    Péter M; Török W; Petrovics-Balog A; Vígh L; Vécsei L; Balogh G
    Sci Rep; 2020 Oct; 10(1):18380. PubMed ID: 33110173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of cerebrospinal fluid myelin basic protein in patients with neurological illness.
    Davies L; McLeod JG; Muir A; Hensley WJ
    Clin Exp Neurol; 1987; 24():5-10. PubMed ID: 2478320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid levels of myelin basic protein and creatin kinase BB as index of active demyelination.
    Matias-Guiu J; Martinez-Vazquez JM; Ruibal A; Codina A
    Acta Neurol Scand; 1986 Feb; 73(2):203-7. PubMed ID: 2422866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease.
    Peng L; Bi C; Xia D; Mao L; Qian H
    Mult Scler Relat Disord; 2019 May; 30():123-128. PubMed ID: 30771578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of 2',3'-cyclic nucleotide 3'-phosphohydrolase in human cerebrospinal fluid.
    Banik NL; Mauldin LB; Hogan EL
    Ann Neurol; 1979 Jun; 5(6):539-41. PubMed ID: 224801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid C9 in demyelinating disease.
    Compston DA; Morgan BP; Oleesky D; Fifield R; Campbell AK
    Neurology; 1986 Nov; 36(11):1503-6. PubMed ID: 3762967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cerebrospinal fluid phospholipids and cerebrosides in several demyelinating diseases].
    Drobysheva NA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(2):218-24. PubMed ID: 1266483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of myelin basic protein in the cerebrospinal fluid in neurologic diseases].
    Bürgisser P; Matthieu JM; de Tribolet N; Gautier E
    Schweiz Med Wochenschr; 1982 May; 112(18):643-7. PubMed ID: 6177033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosis.
    Khalil M; Renner A; Langkammer C; Enzinger C; Ropele S; Stojakovic T; Scharnagl H; Bachmaier G; Pichler A; Archelos JJ; Fuchs S; Seifert-Held T; Fazekas F
    Mult Scler; 2016 Oct; 22(12):1560-1568. PubMed ID: 26762671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An adult case of adrenoleukodystrophy with features of olivo-ponto-cerebellar atrophy: II. Lipid biochemical studies.
    Taketomi T; Hara A; Kitazawa N; Takada K; Nakamura H
    Jpn J Exp Med; 1987 Feb; 57(1):59-70. PubMed ID: 3476777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
    Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
    J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The fatty acid profile of cerebrospinal fluid lipids in demyelinating disorders].
    Seidel D; Lindlar F
    Z Neurol; 1970; 198(2):223-36. PubMed ID: 4099802
    [No Abstract]   [Full Text] [Related]  

  • 15. Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis.
    Antonelou RCh; Emmanouilidou E; Gasparinatos G; Velona T; Voumvourakis KI; Stefanis L
    J Neurochem; 2015 Aug; 134(4):748-55. PubMed ID: 25962981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sialic acid and fatty acid concentrations in lymphocytes, red blood cells and plasma from patients with multiple sclerosis.
    Cherayil GD
    J Neurol Sci; 1984 Jan; 63(1):1-10. PubMed ID: 6699649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis.
    Fialová L; Bartos A; Svarcová J; Zimova D; Kotoucova J; Malbohan I
    J Neuroimmunol; 2013 Sep; 262(1-2):113-20. PubMed ID: 23870535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid composition of myelin in multiple sclerosis.
    Fewster ME; Hirono H; Mead JF
    J Neurol; 1976 Aug; 213(2):119-31. PubMed ID: 60471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis.
    Cantó E; Tintoré M; Villar LM; Borrás E; Alvarez-Cermeño JC; Chiva C; Sabidó E; Rovira A; Montalban X; Comabella M
    J Neuroinflammation; 2014 Nov; 11():181. PubMed ID: 25406498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cerebrospinal fluid proteins in multiple sclerosis.
    Rosenthal A
    Clin Lab Med; 1986 Sep; 6(3):457-75. PubMed ID: 3091313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.